## UCTT: Ultra Clean Holdings, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -2.3% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-6.4% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($22.92)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Neutral (Bullish: 0, Bearish: 1)

**1. Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ultra Clean Holdings, Inc. (UCTT) and Encourages Shareholders to Learn More About the Investigation**
- Source: MyStateline | 20251214T190940 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Ultra Clean Holdings, Inc. (UCTT) due to potential corporate wrongdoing by its officers and/or directors. The firm is encouraging shareholders who purchased UCTT securities before May 6, 2024, and still hold them, to contact the firm to assist with the investigation. The representation of investors in class actions is conducted on a contingency fee basis.

**2. 93,993 Shares in Ultra Clean Holdings, Inc. $UCTT Bought by Coppell Advisory Solutions LLC**
- Source: MarketBeat | 20251214T100907 | Neutral | Relevance: 100%
- Coppell Advisory Solutions LLC has acquired a new stake of 93,993 shares in Ultra Clean Holdings, Inc. (NASDAQ:UCTT), valued at approximately $2.14 million. This acquisition makes Coppell Advisory Solutions LLC own about 0.21% of Ultra Clean, with institutional investors now holding 96.06% of the stock. Despite a recent ~7% stock drop and mixed analyst sentiment, Ultra Clean slightly surpassed its last quarter's earnings and revenue estimates.

**3. Ultra Clean Holdings, Inc. $UCTT Shares Sold by AWM Investment Company Inc.**
- Source: MarketBeat | 20251213T100905 | Neutral | Relevance: 100%
- AWM Investment Company Inc. significantly reduced its stake in Ultra Clean Holdings, Inc., selling 33.1% of its holdings. Several other institutional investors also adjusted their positions, while director David T. Ibnale sold a substantial amount of shares. The company's stock experienced a 7.2% decline, and analysts maintain a "Moderate Buy" rating with an average target price of $33.33.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 3 ($0.63M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 60.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Blackrock Inc.: 14.8% (-1.1%)
- Vanguard Group Inc: 10.3% (+1.5%)
- Shapiro Capital Mana: 8.1% (-11.0%)
- Frontier Capital Man: 6.7% (+10.1%)
- Invesco Ltd.: 4.6% (+8.9%)

### Key Risks

1. High beta (1.94) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.55 indicates undervaluation relative to growth. Forward P/E 17.2x attractive for 41% earnings growth. Balance sheet: strong liquidity (3.2x). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $1.2B |
| Beta | 1.94 |
| 52W Range | $16.66 - $40.10 |
| Short Interest | 5.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.55 |
| Forward P/E | 17.2 |
| Current P/E | 24.3 |
| YoY Growth | 41.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 4.0% to -2.3% (-6.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.3pp (needs >3.0% for momentum thesis). RSI neutral at 48. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.33% (CS: 13) | Weak |
| RSI_14 | 47.8 | Neutral |
| MACD Histogram | 0.22 | Bullish |
| vs SMA20 | 1.021x | Above |
| vs SMA50 | 0.961x | Below |
| vs SMA200 | 1.074x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $25.64
- **Stop Loss:** $22.92 (10.6% risk)
- **Target:** $28.36 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 367
- **Position Value:** $9,409.88
- **Portfolio %:** 9.41%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-23 (Est: $0.23)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.22 | $0.28 | +28.7% |
| 2025Q2 | $0.27 | $0.27 | 0.0% |
| 2025Q1 | $0.31 | $0.28 | -10.4% |
| 2024Q4 | $0.44 | $0.51 | +15.2% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*